Company cbdMD, Inc.

YCBD

US12482W4087

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:10:00 2025-07-09 pm EDT			5-day change	1st Jan Change
0.9400 ^USD	+8.80%		+2.31%	-68.67%

May. 15	CbdMD, Inc., Q2 2025 Earnings Call, May 15, 2025
May. 15	CbdMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025	CI

Business description: cbdMD, Inc.

cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.

Number of employees: 42

Geographical breakdown of sales: cbdMD, Inc.

Fiscal Period: September	2020	2021	2022	2023	2024
United States	41.88M	44.48M	35.4M	24.16M	19.48M

See all geographic segments

Executive Committee: cbdMD, Inc.

Manager	Title	Age	Since
T. Kennedy CEO	Chief Executive Officer	45	2023-02-28
Zeb Booker CTO	Chief Tech/Sci/R&D Officer	-	2018-12-31
Sibyl Swift CTO	Chief Tech/Sci/R&D Officer	44	-
Bradley Whitford AUD	Comptroller/Controller/Auditor	44	2024-03-28
Shannon Charles SAM	Sales & Marketing	-	2022-12-31

See CBDMD, INC. governance

Composition of the Board of Directors: cbdMD, Inc.

Director	Title	Age	Since
Jeffrey Porter BRD	Director/Board Member	65	2025-04-09
T. Kennedy BRD	Director/Board Member	45	2024-12-17
Bakari Sellers BRD	Director/Board Member	40	2017-02-28
Scott Stephen CHM	Chairman	59	2022-06-02
William Raines BRD	Director/Board Member	65	2019-04-18
Sibyl Swift BRD	Director/Board Member	44	-
Kevin Roe BRD	Director/Board Member	52	2025-04-09

Composition of the Board of Directors

Shareholders: cbdMD, Inc.

Name	Equities	%	Valuation
Jeffrey Porter 6.456 %	575,102	6.456 %	512 991 $
Kevin Roe 0.2821 %	25,128	0.2821 %	22 414 $
Citadel Securities GP LLC 0.1773 %	15,795	0.1773 %	14 089 $
William Raines 0.1359 %	12,104	0.1359 %	10 797 $
Virtu Financial LLC 0.0997 %	8,883	0.0997 %	7 924 $

List of CBDMD, INC. shareholders

Company details: cbdMD, Inc.

cbdMD, Inc.

2101 Westinghouse Boulevard Suite A

28273, Charlotte

http://www.cbdmd.com

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
CBDMD, INC.	+8.80%	+2.31%	-79.71%	-99.29%	8.37M
ELI LILLY AND COMPANY	+1.19%	+0.98%	-15.61%	+138.12%	706B
JOHNSON & JOHNSON	+0.31%	+0.46%	+6.28%	-12.34%	376B
ABBVIE INC.	+0.45%	-0.07%	+13.43%	+24.71%	337B
NOVO NORDISK A/S	+0.32%	+1.60%	-54.43%	+9.72%	309B
ROCHE HOLDING AG	+0.15%	+1.24%	+4.74%	-20.11%	262B
NOVARTIS AG	+1.17%	+1.92%	+0.37%	+18.87%	240B
ASTRAZENECA PLC	+2.06%	+3.65%	-12.44%	-5.18%	218B
MERCK & CO., INC.	+2.88%	+1.60%	-33.58%	-9.78%	210B
AMGEN INC.	-0.16%	-0.11%	-6.14%	+19.33%	159B
Average	+1.19%	+0.70%	-17.71%	+6.40%	281.77B
Weighted average by Cap.	+0.24%	+0.44%	-10.78%	+36.70%